Stockscreener 앱 받기
8.57
1.90%
0.16
시간 외 거래:
8.57
전일 마감가:
$8.41
열려 있는:
$8.7
하루 거래량:
76,875
Relative Volume:
0.96
시가총액:
$236.53M
수익:
$21.25M
순이익/손실:
$-16.05M
주가수익비율:
-14.05
EPS:
-0.61
순현금흐름:
$-17.14M
1주 성능:
-1.61%
1개월 성능:
+10.44%
6개월 성능:
+49.56%
1년 성능:
+30.44%
1일 변동 폭
$8.365
$8.76
1주일 범위
$8.28
$8.9625
52주 변동 폭
$3.96
$9.30
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
명칭
Fennec Pharmaceuticals Inc
전화
(919) 636-4530
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
FENC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.57 | 240.56M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 개시 | CapitalOne | Overweight |
| 2022-08-08 | 재개 | Craig Hallum | Buy |
| 2020-06-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 개시 | Goldman | Buy |
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Is Fennec Pharmaceuticals Inc. a good long term investmentHigh-profit trading signals - jammulinksnews.com
Fennec Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
How To Trade (FENC) - news.stocktradersdaily.com
What drives Fennec Pharmaceuticals Inc. stock priceJaw-dropping returns - jammulinksnews.com
What analysts say about Fennec Pharmaceuticals Inc. stockExponential return rates - Autocar Professional
Why Fennec Pharmaceuticals Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
What makes Fennec Pharmaceuticals Inc. stock price move sharplyFree Elite Traders Group - Newser
(FENC) Long Term Investment Analysis - news.stocktradersdaily.com
Fennec Pharmaceuticals (TSE:FRX) Reaches New 52-Week High – Still a Buy? - Defense World
Long Term Trading Analysis for (FENC) - news.stocktradersdaily.com
Bank of America Corp DE Has $226,000 Stock Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
(FENC) Investment Analysis and Advice - news.stocktradersdaily.com
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmac - GuruFocus
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus
Fennec Pharmaceuticals elects board members, shareholders approve proposals By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals elects board members, shareholders approve proposals - Investing.com
Fennec Pharmaceuticals Approves Proposals at Shareholder Meeting - TipRanks
Fennec Announces Results of Annual Meeting - TradingView
Northern Trust Corp Sells 2,976 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
FENC Meeting Scheduled in Toronto Hosted by Craig-Hallum | FENC Stock News - GuruFocus
Indian Pharma Co. Hit With Patent Suit Over Fennec's Cancer Drug - Law360
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Acquired by BNP Paribas Financial Markets - Defense World
Q2 EPS Estimate for Fennec Pharmaceuticals Raised by Analyst - Defense World
HC Wainwright Brokers Increase Earnings Estimates for FENC - Defense World
FY2026 Earnings Estimate for TSE:FRX Issued By HC Wainwright - Defense World
Research Analysts Offer Predictions for FENC FY2026 Earnings - Defense World
Fennec Pharmaceuticals (NASDAQ:FENC) Earns Buy Rating from HC Wainwright - Defense World
Don't Ignore The Insider Selling In Fennec Pharmaceuticals - simplywall.st
Fennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month High on Insider Buying Activity - Defense World
Fennec Pharmaceuticals at BioConnect: Strategic Moves and Market Expansion By Investing.com - Investing.com Canada
FENC: HC Wainwright Maintains "Buy" Rating and Price Target | FENC Stock News - GuruFocus
Fennec Pharmaceuticals Inc (FENC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.51%
자본화:
|
볼륨(24시간):